Leucine

ExcipientCAS 61-90-5UNII GMW67QNF9C

1 organisation holds 1 active FDA Type IV Drug Master File for Leucine. 12 valid EDQM Certificates of Suitability are on record for the same substance.

Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity); EDQM Certification Online Database. Methodology

Active Type IV DMFs (1)

HolderDMFFiled asSubmitted
CAMBRIDGE ISOTOPE LABORATORIES INC
United States
21618L-LEUCINE (U-13C6)May 2008

“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.

Valid CEPs for this substance (12)

HolderCountryCertificateIssued
EVONIK REXIM (NANNING) PHARMACEUTICAL CO., LTD. Nanning CNCN
CEP 2025-632 - Rev 01
Leucine, Process 2
Oct 2026
AJINOMOTO CO INCJP
CEP 2008-233 - Rev 02
Leucine
Aug 2026
AJINOMOTO CO INCJP
CEP 2012-052 - Rev 02
Leucine
Aug 2026
EVONIK REXIM (NANNING) PHARMACEUTICAL CO., LTD. Nanning CNCN
CEP 2025-632 - Rev 00
Leucine, Process 2
Jun 2026
SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai CNCN
CEP 2010-189 - Rev 01
Leucine
Oct 2025
YICHANG SANXIA PROUDIN BIOPHARMACEUTICAL CO., LTD. Yichang CNCN
CEP 2023-459 - Rev 00
Leucine
Jun 2024
EVONIK REXIM (NANNING) PHARMACEUTICAL CO., LTD. Nanning CNCN
CEP 2008-097 - Rev 02
Leucine
Nov 2023
TIANJIN TIANYAO PHARMACEUTICALS CO LTDCN
R0-CEP 2020-207 - Rev 00
Leucine
Oct 2022
AMINO GMBHDE
R1-CEP 2014-156 - Rev 00
Leucine, Obtained from fermentation
Dec 2021
AMINO GMBHDE
R1-CEP 2014-088 - Rev 00
Leucine, From feathers
Dec 2019
AMINO GMBHDE
R1-CEP 1997-011 - Rev 04
Leucine
Nov 2013
Kyowa Hakko Bio Co., Ltd.JP
R1-CEP 1999-160 - Rev 03
Leucine
Aug 2013

Certification Online Database, European Directorate for the Quality of Medicines & HealthCare. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

What these records establish

  • A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
  • Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
  • The holder is the organisation that filed. It is usually, but not always, the manufacturer.
  • Many excipients are supplied without any DMF, so this list is not every supplier of Leucine.

How to qualify an excipient supplier

For suppliers

Do you supply Leucine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.